Engine No. 1 LLC Eli Lilly & CO Transaction History

Engine No. 1 LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $1.28 Million - $1.59 Million	-5,443 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $263,299 - $326,755	1,171 Added 27.41%	5,443 $1.5 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $383,811 - $472,333	1,732 Added 68.19%	4,272 $987,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $458,597 - $593,191	2,540 New	2,540 $583,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Engine No. 1 LLC, based on Form 13F filings with the SEC.

Stay updated on Engine No. 1 LLC with notifications on news.